iX Biopharma Ltd. (SGX:42C)
0.1170
-0.0010 (-0.85%)
Oct 31, 2025, 5:04 PM SGT
iX Biopharma Market Cap
iX Biopharma has a market cap or net worth of 103.99 million as of October 31, 2025. Its market cap has increased by 351.18% in one year.
Market Cap
103.99M
Enterprise Value
108.96M
Revenue
7.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since July 22, 2015, iX Biopharma's market cap has decreased from 330.51M to 103.99M, a decrease of -68.53%. That is a compound annual growth rate of -10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 103.99M | 370.92% |
| Dec 31, 2024 | 22.08M | -35.96% |
| Dec 28, 2023 | 34.48M | -65.12% |
| Dec 30, 2022 | 98.85M | -32.86% |
| Dec 31, 2021 | 147.23M | -17.14% |
| Dec 31, 2020 | 177.70M | 21.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haw Par Corporation | 3.29B |
| Raffles Medical Group | 1.84B |
| Thomson Medical Group | 1.59B |
| Riverstone Holdings | 1.30B |
| Q & M Dental Group (Singapore) | 505.42M |
| Vicplas International | 50.09M |
| Cordlife Group | 38.45M |